Τετάρτη 17 Φεβρουαρίου 2016

Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol.

Condition:   Adenocarcinoma of the Esophagus or Esophagogastric Junction.
Interventions:   Radiation: Radiation therapy;   Drug: Oxaliplatin and fluorouracil.
Sponsor:   Lund University Hospital
Recruiting - verified February 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1U7YzfC
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου